Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07864181
PHASE1/PHASE2

TheraCal PT vs. Formocresol in Primary Molar Pulpotomies

Sponsor: Hama University

View on ClinicalTrials.gov

Summary

This prospective, randomized, parallel-group clinical trial evaluated the 12-month clinical and radiographic success rates of TheraCal PT versus formocresol in primary molar vital pulpotomies among 50 children aged 5 to 8 years. At the conclusion of the follow-up period, both materials demonstrated a 100% clinical success rate, while radiographic success rates were 92% for the formocresol group and 80% for the TheraCal PT group, showing no statistically significant differences between the two treatments.

Official title: TheraCal PT Versus Formocresol in Primary Molar Pulpotomies: Clinical and Radiographic Outcomes at 12 Months Follow-Up

Key Details

Gender

All

Age Range

5 Years - 8 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2024-01-01

Completion Date

2025-12-23

Last Updated

2026-10-07

Healthy Volunteers

No

Interventions

DRUG

Dual cured resin modified

Total absence of pulpal and periradicular radiographic pathology, explicitly evaluated via standardized periapical radiographs using the paralleling technique. Success is characterized by the absence of new or progressive periapical radiolucency, inter-radicular furcation radiolucency, or pathological internal or external root resorption. The appearance of any single radiographic lesion is defined as radiographic failure.

Locations (1)

Hama University

Hama, Syria